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Abstract
Background: CT texture analysis (CTTA) has been successfully used to assess tissue heterogeneity in multiple
diseases. The purpose of this work is to demonstrate the value of three-dimensional CTTA in the evaluation of
diffuse liver disease. We aimed to develop CTTA based prediction models, which can be used for staging of fibrosis
in different anatomic liver segments irrespective of variations in scanning parameters.
Methods: We retrospectively collected CT scans of thirty-two chronic hepatitis patients with liver fibrosis. The CT
examinations were performed on either a 16- or a 64-slice scanner. Altogether 354 anatomic liver segments were
manually highlighted on portal venous phase images, and 1117 three-dimensional texture parameters were
calculated from each segment. The segments were divided between groups of low-grade and high-grade fibrosis
using shear-wave elastography. The highly-correlated features (Pearson r > 0.95) were filtered out, and the
remaining 453 features were normalized and used in a classification with k-means and hierarchical cluster analysis.
The segments were split between the train and test sets in equal proportion (analysis I) or based on the scanner
type (analysis II) into 64-slice train 16-slice validation cohorts for machine learning classification, and a subset of
highly prognostic features was selected with recursive feature elimination.
Results: A classification with k-means and hierarchical cluster analysis divided segments into four main clusters. The
average CT density was significantly higher in cluster-4 (110 HU ± SD = 10.1HU) compared to the other clusters (c1:
96.1 HU ± SD = 11.3HU; p < 0.0001; c2: 90.8 HU ± SD = 16.8HU; p < 0.0001; c3: 93.1 HU ± SD = 17.5HU; p < 0.0001); but
there was no difference in liver stiffness or scanner type among the clusters. The optimized random forest classifier
was able to distinguish between low-grade and high-grade fibrosis with excellent cross-validated accuracy in both
the first and second analysis (AUC = 0.90, CI = 0.85–0.95 vs. AUC = 0.88, CI = 0.84–0.91). The final support vector
machine model achieved an excellent prediction rate in the second analysis (AUC = 0.91, CI = 0.88–0.94) and an
acceptable prediction rate in the first analysis (AUC = 0.76, CI = 0.67–0.84).
Conclusions: In conclusion, CTTA-based models can be successfully applied to differentiate high-grade from low-
grade fibrosis irrespective of the imaging platform. Thus, CTTA may be useful in the non-invasive prognostication of
patients with chronic liver disease.
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Background
Hepatic fibrosis can result from various types of chronic
damaging factors, including viral infections, toxins,
metabolic diseases, alcoholic or non-alcoholic steatohe-
patitis, autoimmune disorders, and chronic biliary dis-
eases, among others. Patients with advanced-stage
fibrosis and cirrhosis are at increased risk of developing
portal hypertension, hepatic insufficiency, and hepatocel-
lular carcinoma. Therefore, early detection and staging
of liver fibrosis have great clinical importance.
Percutaneous liver biopsy is the current gold standard
method for staging fibrosis. It is a highly invasive, painful
procedure with considerable sampling variability and po-
tential of complications. In recent guidelines on the
treatment of chronic viral hepatitis, non-invasive
methods are recommended for the initial assessment of
fibrosis. Meanwhile, liver biopsy is reserved for cases
where there is uncertainty or potential additional etiolo-
gies [1–3]. Non-invasive methods have emerged in re-
cent years, including ultrasound-based and MRI-based
elastography techniques, which offer a promising new
paradigm for diagnosing and staging fibrosis [3, 4]. CT
has been frequently used for follow-up patients with
hepatic fibrosis and to identify liver malignancies. Al-
though classic signs of liver cirrhosis are well
recognizable on CT scans, conventional CT techniques
have low sensitivity for quantifying the more subtle
architectural changes of the parenchyma caused by
fibrosis.
CT-texture analysis (CTTA) is one of the most devel-
oping areas of radiomics that can quantitatively describe
the heterogeneity and the distribution of pixel or voxel
grey-levels on CT scans. CTTA builds on complex quan-
titative imaging features invisible to the human eye and
that are constructed by various mathematical transfor-
mations of the original image. CTTA has been used with
success for objective and quantitative assessment of tis-
sue heterogeneity in benign and malignant lesions in
many different organs, including breast, lung, thyroid,
and liver [5]. Previous studies have already achieved sig-
nificant success with radiomic analysis of CT images in
liver fibrosis. However, these methods were tested on a
single cross-section of the liver [6, 7], or smaller regions
of interest [8, 9], and they did not assess cirrhosis related
changes in all three dimensions of the liver volume. Pre-
vious reports did not analyze the effect of variable scan-
ning parameters such as the dynamic of contrast
enhancement and differences between scanners during
CTTA based characterization of liver fibrosis.
This work aims to demonstrate the value of three-
dimensional CTTA in the evaluation of diffuse liver
disease. This paper attempts to identify the source of
variance in large scale texture datasets extracted from
volumes of fibrotic liver parenchyma. Finally, we aimed
to develop CTTA based prediction models, which can
be used for staging fibrosis in different anatomic liver




The institutional ethics committee of our university has
approved the present study according to the World
Medical Association guidelines and Declaration of
Helsinki, revised in 2000 in Edinburgh. As this is a retro-
spective case-control study, the need for written patient
consent was waived by the ethics committee; in compli-
ance with our institutional protocols, written informed
consent was obtained before the CT and ultrasound
scans from all patients. The CT scans of sixteen female
(ages 22–72, mean age 52 years) and sixteen male pa-
tients (ages 42–75, mean age 63 years) with chronic liver
diseases who had both an abdominal CT scan and a
point shear wave elastography (pSWE) measurement at
our institution between September 2016 and January
2019 were retrospectively selected. Two patients were
excluded from the study due to a lack of contrast-
enhanced CT. The shear wave elastography measure-
ment was performed within six months of the CT scan.
All patients in this study had been clinically diagnosed
and followed for chronic liver disease due to various eti-
ologies (Table 1).
The liver pSWE was completed with the S-Shearwave™
application and an RS85 Prestige ultrasound scanner
(Samsung Medison, Hongcheon, Korea) as part of the
patients’ regular follow-up. Patients were divided into
two groups according to their pSWE measurements:
low-grade fibrosis including F0, F1, and F2 METAVIR
stages (11 patients, pSWE< 9.5 kPa), and high-grade fi-
brosis including F3 and F4 METAVIR stages (21 pa-
tients, pSWE≥9.5 kPa) as described previously [10].
Table 1 Distribution of demographics, etiology, and fibrosis
stage in the patient cohort
Patients Number Age (range)
Female 16 52 years (22–72)
Male 16 63 years (42–75)
Etiology of liver fibrosis Ratio (%)
chronic HCV 14 43.8% (14/32)
toxic hepatitis 7 21.9% (7/32)
PBC, PSC, AIH 3 9.4% (3/32)
chronic HBV 1 3.1% (1/32)
Unknown 7 21.9% (7/32)
Fibrosis stage
Low-grade (< 9.5 kPa) 11 34.4% (12/32)
High-grade (≥9.5 kPa) 21 65.6% (20/32)
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CT examination and texture analysis
The patients were examined according to our routine
diagnostic protocols on either a 16-slice Brilliance or a
64-slice Ingenuity Core 64 CT scanner (Philips Health-
care, Best, the Netherlands). The scanners had the fol-
lowing settings: tube voltage of 120 kV; automatic tube
current modulation in the range of 193-458mAs; rota-
tion time 0.5 s, collimation 16 × 1.5 mm, or 64 × 0.625
mm, spiral pitch 0.813 or 0.798, pixel spacing 0.916 or
0.695 mm for the 16 and 64-slice scans respectively. The
16-slice acquisitions were routinely reconstructed with
filtered back projection, and 64-slice scans with the
iDose4™ hybrid iterative reconstruction kernel. A non-
ionic, iodinated contrast agent (range of concentration:
350-370 mg/ml) was administered intravenously using a
power injector with an injection rate of 2–3.5 ml/sec.
The amount adjusted to body weight (0.5 g iodine/kg).
The injection rate was adjusted to achieve a fixed injec-
tion time of 30 s. The bolus tracking method was used
for timing the scan, where a region of interest (ROI) was
placed in the lumen of the descending aorta above the
diaphragm. The portal venous (PV) phase scan was
initiated 60 s after the aortic enhancement in the ROI
exceeded the 150 Hounsfield Unit (HU) threshold.
The PV phase series were reconstructed to 5 mm slice
thickness with no interslice gap. The anonymized images
were transferred in DICOM format for segmentation
and feature extraction with the 3DSlicer 4.8.1 software
(www.slicer.org) [11]. Whole liver maps and right and
left lobes, and the eight anatomical liver segments, were
manually labeled in consecutive slices covering the en-
tire liver volume (Fig. 1). The axial slice with the greatest
cross-section at the bifurcation of the portal vein was
used to separate upper and lower segments in each lobe,
which provided a good approximation of the anatomical
liver segments.
In general, twelve liver segments, including nine ana-
tomic liver segments, right and left lobes, and the whole
liver were manually annotated in 30 patients on PV
scans. One of the patients had prior resection of the
right posterior-lateral segment (S6), we also detected cir-
cumscribed lesions such as hepatic cysts in the S3 seg-
ment of one and in the S4A and S4B segments of two
patients. Therefore, altogether six liver segments were
Fig. 1 The anatomic liver segments were manually segmented for the three-dimensional texture analysis. a is the anterior, b is the inferior and c
is the posterior view of the segmented liver on a three-dimensional volume reconstruction. d The contrast-enhanced portal venous phase axial
images of a cirrhotic liver after manual segmentation show the upper II., IV.a, VII., VIII. and (e) the lower I., III., IV.b, V., VI., Couinaud segments
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omitted from the analysis and the final dataset consisted
of 354 liver segments.
Altogether, 1117 texture parameters (TP) were calcu-
lated for each segment using the PyRadiomics package
[12, 11]. From the original images, 18 first-order inten-
sity features, 13 shape-based features, 23 grey level co-
occurrence matrix features (GLCM), 16 grey level run-
length matrix features (GLRLM), 16 grey level size zone
matrix features (GLSZM), 14 grey level dependence
matrix features (GLDM), and five neighboring grey-tone
difference matrix features (NGTDM) were extracted.
After the original three-dimensional images were trans-
formed with wavelet and Laplacian of Gaussian (LoG)
filters, 276 features were calculated with LoG kernel
sizes of 3 mm, 6mm, and 9mm, and 736 features after
discrete wavelet transformations. The average CT dens-
ity was measured in HU in all anatomic segments in the
portal venous phase using circular ROIs. The texture
analysis data are available in Additional file 1 and
Additional file 2.
Analysis of the texture dataset
The TPs were log-transformed, and a correlation matrix
was calculated using the Pearson correlation. Highly cor-
related features with an r coefficient > 95% were dis-
carded. The remaining 453 parameters were median
centered and scaled to the interquartile range.
A K-means clustering was used for the unsupervised
classification of the liver segments. The optimal number
of k was determined with silhouette analysis [13]. We
compared the continuous variables among the k-mean
clusters with ANOVA and post hoc Tukey’s tests. Con-
tingency tables were calculated for the categorical vari-
ables, and the F-test was used to determine significance
in the pairwise comparisons. A hierarchical cluster ana-
lysis was performed on each of the k-means clusters.
The Pearson correlation was used to calculate the dis-
tance matrix, the dendrograms were built with Ward. D
linkage, and heatmaps were drawn to visualize the
features.
We classified liver segments as either low-grade or
high-grade fibrosis based on a 9.5 kPa SWE cutoff. We
performed a receiver-operating characteristics (ROC)
analysis with each of the texture parameters. The area
under the curve (AUC) was used as a performance
metric of the features. We calculated the AUC estimates
and the influence curve based on 95% confidence inter-
vals using 5-fold cross-validation [14]. A univariate lin-
ear regression model was constructed to identify
predictors of liver stiffness. We used bootstrapping with
1000 replications to calculate the 95% confidence inter-
vals of the model coefficients. A principal component
analysis showed that the first 45 components explain
95% of the total variance of the dataset. Therefore, p-
values from multiple comparisons were not corrected
with the number of test hypotheses as in a Bonferroni
correction, rather a p < 0.0011 (0.05/45) cutoff was used
to determine statistical significance [15].
Four machine learning models were constructed for
the supervised classification of low-grade and high-grade
fibrosis. In the first analysis, the samples were split be-
tween the train and test sets in equal proportions. In a
second analysis, the cases were split between the train
and test sets based on the scanner types. Features with
more than 10% univariate false discovery rate (FDR)
were filtered out in the training set. We chose random
forest (RFC) and the support vector machine (SVM)
classifiers for the models. A grid-search pipeline was
used to determine the optimal hyperparameters of the
models. We used recursive feature elimination (RFE) to
calculate the optimal number of features in the classifier,
rank features by relevance, and then fit the model on the
training set. Ten repeats of a stratified 5-fold cross-
validation were performed at each step. The final
model’s performance was also validated on the inde-
pendent test set (Fig. 2). The categorical variables are re-
ported as ratio and percentage, the continuous variables
as mean and standard deviation (SD). The AUC scores
are reported as median and 95% confidence interval
(CI). We used the R × 64 3.5.3 software (www.r-project.
org) for data analysis.
Results
Unsupervised classification of liver segments
The texture analysis extracted 1117 parameters from the
354 anatomic liver segments, which were manually seg-
mented on the portal venous phase CT scans of 30 pa-
tients. After the highly correlated features with a
Pearson r > 0.95 were filtered out, the remaining log-
transformed and normalized 453 parameters were used
for the k-means clustering. The silhouette score showed
that the optimal k value was four. The resulting k-means
clusters contained c1 = 213, c2 = 57, c3 = 39 and c4 = 45
segments respectively (Fig. 3). We compared the distri-
bution of anatomic segments, scanner type, liver stiff-
ness, and CT density between the four clusters. The
average CT density was significantly higher in c4
(mean ± SD = 110HU ± 10.1HU) than in c1 (96.1HU ±
11.3HU; p < 0.0001), c2 (90.8HU ± 16.8HU; p < 0.0001)
or c3 (93.1HU ± 17.5HU; p < 0.0001); also the density of
segments in c2 was significantly lower (p < 0.035) than
segments in c1. Meanwhile, there was no significant dif-
ference in the distribution of the rest of the variables.
Univariate analysis of the texture parameters
A ROC analysis was performed to test individual texture
parameters’ diagnostic ability to differentiate between
low-grade and high-grade fibrosis. A cross-validated
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AUC estimate was calculated to evaluate the individual
prediction accuracy of the texture features. A Manhattan
plot showed that GLCM features had the highest AUC
values, while the shape features performed worse than
other metrics (Fig. 4). The top three parameters had a
cross-validated AUC > 0.7 and included: wavelet-LLH
filtered GLCM Correlation (AUC = 0.72 CI = 0.66–0.78),
wavelet-HLH filtered GLCM Informational Measured
Correlation (Imc2) (AUC = 0.71 CI = 0.65–0.77) and
wavelet-LHL filtered GLCM Correlation (AUC = 0.70
CI = 0.64–0.76). These metrics quantify the complexity
of the texture as they describe the correlation between
the probability distributions of the GLCM elements.
A univariate linear regression analysis was used to find
a relationship between texture parameters and liver
stiffness. The R2 and β coefficients, and the p-value were
calculated for each parameter from 1000 bootstrap repli-
cations. Thirty-eight features showed significant (p <
0.0011) association with liver stiffness, although their R2
was low. The best predictor of liver stiffness was
wavelet-HLH filtered GLCM Imc2 (R2 = 0.074, β = −
2.593, p < 0.0001). The results of the univariate analysis
of the texture features are included in Additional file 3.
Construction of prediction models for the detection of
advanced fibrosis
We trained SVM and RFC machine learning classifiers
to differentiate between liver segments with low-grade
and high-grade fibrosis based on selected texture fea-
tures. At first, we randomly split the segments between
Fig. 2 Flow chart shows the steps of data analysis. We manually highlighted anatomic liver segments on portal venous phase CT scans of
patients with chronic liver diseases. A three-dimensional texture analysis generated 1117 features out of each segment. The highly correlated
features were filtered out from the dataset before normalization to the interquartile range. An unsupervised k-means and hierarchical clustering
were performed with all segments. The univariate classification rate of the features for low-grade vs. high-grade fibrosis was tested in a receiver
operating curve analysis. The cutoff at 9.5 kPa of shear-wave elastography was used as a reference. A machine learning pipeline was used to build
models that could predict high-grade vs. low-grade fibrosis based on selected texture features. In the first analysis, the segments were randomly
split between equal size train and test sets. In the second analysis, the segments scanned with a 64-slice scanner constituted the train set, and
segments scanned with a 16-slice scanner were assigned to the test set. The models were optimized and validated on the corresponding
training and the test sets, respectively
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the train and test sets in a 50:50 ratio. The proportion of
cirrhotic and non-cirrhotic liver segments was similar in
the training (non-cirrhotic 48, 27%, cirrhotic 129, 73%)
and test (non-cirrhotic: 59, 33%, cirrhotic 118, 67%)
groups. Next, features with an FDR greater than 10%
were removed from the training set. The filtered training
set consisted of 177 segments and 154 features. A grid
search method was used to fine-tune the SVM and RFC
classifiers’ hyperparameters using ten repeats of stratified
5-fold cross-validation of the training set. The less im-
portant texture parameters were removed from the
models during a cross-validated RFE process. In the first
analysis, the optimized RFC model (model 1) included
two features (first-order 90Percentile and wavelet-LHH
filtered GLCM Inverse-Variance) and achieved an excel-
lent cross-validated classification rate (AUC = 0.95, CI =
0.91–0.98) in the training set (Fig. 5A). The optimized
SVM model (model 2) included 18 features, and its
cross-validated accuracy was very good (AUC = 0.88,
CI = 0.81–0.94) for the training set. The diagnostic per-
formance of both models was also evaluated in the test
set, where the RFC (model 1) achieved an excellent
(AUC = 0.90, CI = 0.85–0.95), and the SVM (model 2)
had an acceptable cross-validated accuracy (AUC = 0.76,
CI = 0.67–0.84) (Table 2).
We also predicted fibrosis in the whole liver (WL) and
right lobe (RL) in each patient using the same models, as
these segments best correspond to the site of SWE mea-
surements. When these two segments were predicted
with the pre-trained machine learning models, the cross-
validated accuracy of the RFC (model 1) was better in
the right lobe (AUC = 0.81, CI = 0.65–0.98) than in the
whole liver (AUC = 0.70, CI = 0.52–0.88). Meanwhile, the
SVM (model 2) had lower, but similar prediction accur-
acy in both right lobe (AUC = 0.67, CI = 0.56–0.78) and
the whole liver (AUC = 0.70, CI = 0.64–0.75) segments.
Fig. 3 K-means and hierarchical cluster analysis of liver segments. Liver segments were grouped by k-means clustering into four clusters. The
optimal number of clusters was determined with the silhouette method. The heatmap was constructed by hierarchical clustering of liver
segments (rows) and texture parameters (columns) in each of the four k-means clusters. For drawing the dendrograms, the Pearson correlation
was used as a distance metric, and linkage was determined by the Ward. D method. The distribution of clinical and technical variables was also
compared among the clusters (color bars)
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In the second analysis, the liver segments were split
based on the type of CT scanner: the segments of pa-
tients who had been scanned with a 64-slice scanner
constituted the training set (177 segments of 15 pa-
tients), and patients who had been scanned with a
16-slice scanner (154 segments of 13 patients) were
assigned to the test set (Fig. 2). Two patients scanned
with another type of scanner were excluded from the
analysis. Thus, we have avoided splitting segments be-
longing to the same patient between the train and
validation sets. The RFC model (model 3) included 28
highest scoring features after RFE and had very good
prediction accuracy for both the training (AUC = 0.84,
CI = 0.82–0.85) and the test (AUC = 0.88, CI = 0.84–
0.91) for differentiating high-grade from low-grade fi-
brosis. Meanwhile, the SVM model (model 4) used 66
highest scoring features, and its classification accuracy
was excellent for the same train (AUC = 0.91, CI =
0.88–0.94) and test sets (AUC = 0.90, CI = 0.87–0.93)
(Fig. 5B) (Table 2). Similar to the first analysis, the fi-
brosis in the whole liver and right lobe could be pre-
dicted with both the RFC (model 3) (WL AUC = 0.85,
CI = 0.77–0.92, RL AUC = 0.83, CI = 0.79–0.86) and
the SVM (model 4) (WL AUC = 0.83, CI = 0.77–0.88,
RL AUC = 0.85, CI = 0.81–0.89) with very good
accuracy.
There was considerable overlap in the relevant features
selected after RFE among the four prediction models.
We found that 27 relevant features were selected for at
least two, and seven out of these features for three
models (Additional file 3).
Discussion
The timely diagnosis of liver fibrosis is crucial as many
times, the progressive course of chronic liver disease can
lead to life-threatening complications due to cirrhosis,
liver failure, and increased risk of liver cancer. The gold
standard method for assessing liver fibrosis is a percu-
taneous liver biopsy. Bedossa et al. studied the variability
in the distribution of fibrosis in the liver parenchyma
and its impact on the diagnosis and staging of fibrosis
with liver biopsy in patients with chronic hepatitis C
virus infection. They stressed that sampling variability
caused by the heterogeneity of liver fibrosis is limiting
accurate assessment [16]. The potential complications
and the cost of liver biopsy can be significant. According
to recent guidelines, non-invasive markers, including
elastography, are recommended for the initial
Fig. 4 Manhattan plot shows AUC values of different classes of texture features. We calculated the area under the curve (AUC) estimate from 5-
fold cross-validation to evaluate individual texture parameters (TP) as classifiers of low-grade vs. high-grade fibrosis. Among the different classes
of texture parameters, the features calculated from a grey level co-occurrence matrix (GLCM) had the highest AUC (green dots). Meanwhile, the
AUC of the shape-based features (blue dots) did not reach up to the accuracy of other classes. The solid line highlights AUC = 0.5, where features
do not have discriminatory power, the best classifiers exceeded AUC = 0.7 (dotted line)
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assessment of liver fibrosis in both HBV and HCV asso-
ciated liver disease. In contrast, a liver biopsy is only
preferred in selected cases where there is uncertainty or
potential additional etiologies [1–3]. The American As-
sociation for the Study of Liver Diseases encourages the
development of new effective non-invasive alternatives
to liver biopsy [17].
Image analysis techniques are gaining popularity for
the non-invasive detection of liver fibrosis, as these can
be retrospectively applied to CT scans and do not re-
quire unique instrumentation. A handful of studies have
examined the value of CTTA, and their results indicated
that the performance of CTTA to discriminate between
stages of fibrosis is comparable to other non-invasive
techniques such as elastography [9, 8, 6, 7, 18]. Our
study is based on a direct comparison of SWE and
CTTA. The diagnostic performance of SWE has been
extensively evaluated against liver biopsy in multiple eti-
ologies of liver fibrosis. The results showed that liver
stiffness values correlated with the histological fibrosis
stage, and SWE was an accurate technique for the as-
sessment of significant fibrosis and cirrhosis [19, 10]. Al-
though the SWE evaluates stiffness, a physical property
of the parenchyma, while CTTA quantifies the architec-
tural distortion, we found that CTTA can reproduce the
fibrosis stage determined by SWE with good accuracy.
Fig. 5 ROC curves of the optimized machine learning models. In the first analysis (a) where the liver segments were randomly divided into equal
size train and test sets, the random forest classifier (RFC) was able to differentiate between low-grade and high-grade fibrosis with excellent
accuracy in the training set (AUC = 0.95, blue line). Its diagnostic ability was only slightly worse in the test set (AUC = 0.90, magenta line). The
support vector machine classifier (SVM) achieved very good prediction accuracy in the training set (AUC = 0.88, teal line), and it performed
acceptably in the classification of the test set (AUC = 0.76, orange line). In the second analysis (b) segments of 64-slice scans were used for
training and segments of 16-slice scans for testing the models. The RFC model achieved very good prediction accuracy in both the training
(AUC = 0.84, blue line) and test sets (AUC = 0.88, magenta line). The SVM’s accuracy for the prediction of high-grade fibrosis was excellent in both
the training (AUC = 0.91, teal line) and the test set (AUC = 0.90, orange line) (b)
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The attenuation of liver segments that is predomin-
antly dependent on contrast enhancement was signifi-
cantly different between the four clusters identified by
k-means clustering. Thus, individual variations in the
dynamic of the PV enhancement can significantly in-
fluence TPs. The contrast enhancement irregularities
in part can be attributed to the architectural hetero-
geneity and the disrupted blood supply due to excess
tissue deposition in the parenchyma.
Previous reports found that CTTA in PV is superior to
arterial and non-enhanced scans but most effective in
the equilibrium phase for detecting cirrhosis (8). How-
ever, equilibrium phase scans are less frequently per-
formed during abdominal CT; thus, it is not an optimal
technique to screen for liver fibrosis. Previous studies
uniformly analyzed the liver texture in the PV and
proved that CTTA based classification of fibrosis is feas-
ible [6–9, 18, 20]. Similarly, we performed CTTA on the
PV series and found that CTTA has very good discrim-
inatory power for advanced fibrosis.
We performed three-dimensional CTTA of the liver
volume, this approach, compared to previously described
slice-by slice-based analysis, can detect additional details
of architectural distortion, and identify novel fibrosis-
associated features. We identified wavelet-LLH filtered
GLCM Correlation, wavelet-HLH filtered GLCM Imc2,
and wavelet-LHL filtered GLCM Correlation among the
best predictors of fibrosis stage. GLCM Correlation
showed a positive association with increased liver stiff-
ness. These metrics describe the correlation between a
pixel and it’s neighbor over the whole image. Therefore,
our findings may suggest that a repeating texture pat-
tern, such as cirrhotic nodularity, is detected. Mean-
while, similar to prior reports [8, 6, 7, 18], we found that
histogram-based metrics such as wavelet-LHL filtered
first-order Median, original first-order 10Percentile and
original first-order 90Percentile are highly useful for the
correct classification of low-grade vs. high-grade fibrosis.
All of these features earned a high importance score
during RFE. According to Lubner et al. [7, 18], they
found that grey level intensity and entropy are good pre-
dictors of fibrotic changes, the strong association be-
tween fibrosis stage and pixel intensity-related
parameters can be explained by the expanded extracellu-
lar compartment and collagen deposition during cirrho-
sis, which may result in increased attenuation and tissue
heterogeneity.
Although different types of CT scanners and recon-
struction algorithms were used in our patient cohort, we
could complete a successful analysis of the data set by
normalization and filtering of the texture parameters.
Prior studies have demonstrated that differences in CT
reconstruction algorithms have a limited effect on tex-
ture parameters compared to other texture analysis pa-
rameters such as binning [21]. Previous reports, which
evaluated texture parameters in different stages of liver
fibrosis, achieved similar classification accuracy with
multiple scanners [18]. In their study, Pickhardt et al.
demonstrated that CTTA of the liver could be applied
retrospectively to routine scans performed with either
16- or 64-slice CT scanners, which may have been ob-
tained for other indications [20].
We tested two types of data analysis strategies, which
resulted in a similar classification accuracy of patients
with advanced fibrosis. Based on the visual evaluation of
unsupervised cluster analysis, we concluded that there
was no bias from technical factors, which would univer-
sally affect texture parameters and prevent the correct
classification of the liver segments. Thus, in the first
analysis, each liver segment was considered an inde-
pendent sample and randomly split between train and
test set for the machine learning analysis. RFE proved to
be a useful technique to define a subset of best-
performing features. It constructed highly efficient
models where only a handful of parameters could pre-
dict advanced fibrosis with good to excellent accuracy.
Table 2 The performance of machine learning classifiers in the prediction of low-grade vs. high-grade fibrosis
Modela RFC (Model 1)b SVM (Model 2)b RFC (Model 3)c SVM (Model 4)c
Number of featuresd 2 18 28 66
Train AUC 0.95 (0.91–0.98) 0.88 (0.81–0.94) 0.84 (0.82–0.85) 0.91 (0.88–0.94)
Test AUC 0.90 (0.85–0.95) 0.76 (0.67–0.84) 0.88 (0.84–0.91) 0.90 (0.87–0.93)
Sensitivitye 86% 93% 86% 83%
Specificitye 78% 31% 92% 95%
NPVe 89% 73% 81% 78%
PPV e 73% 69% 94% 96%
a Optimized for the classification of low-grade vs. high-grade fibrosis in liver segments;
b The liver segments were randomly divided into equal size training and test set;
c Segments of patients who had been scanned with a 64-slice scanner constituted the training set, and patients who had been scanned with a 16-slice scanner
were assigned to the test set;
dAfter cross-validated recursive feature elimination;
e Calculated in the test set; RFC random forest classifier, SVM support vector machine classifier, NPV negative predictive value, PPV positive predictive value
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The optimized RFC model consisted of only two features
achieved an excellent diagnostic accuracy in both the
train and test sets. The specificity and negative predict-
ive value of the model were also very good, as they
reached 86 and 89%, respectively. However, we observed
a drop in classification rates between the train and test
sets, AUC 0.95 to 0.9, and AUC 0.88 to 0.76 in the case
of both RFC and SVM models, respectively. This can be
a sign of overfitting of the model on the training set,
which can be in part caused by sharing segments from
the same patients between the train and test sets. The
overfitting was observed even when 10 times repeated
stratified 5-fold cross-validation was used during all
steps of model building, which is a universally accepted
technique in machine learning [22]. Therefore, during a
second analysis, segments were divided into train and
test sets according to the scanner types. Thus, we could
prevent potential overfitting of models by splitting seg-
ments belonging to the same patient between the train
and test groups. This time, the classification rate did not
drop in the test set with either model, which indicated
that the models’ overfitting could be reduced.
The diagnostic accuracy of all four models is compar-
able, or in the case of the model 1, 2 and 3 (90, 88, and
90%, respectively) exceeds the performance of multivari-
ate models described by other authors in previous stud-
ies. Kayaalti et al. used CTTA for pairwise comparisons
between consecutive stages of fibrosis, and reported 94%
mean classification accuracy with an SVM [9]. Another
study by Zhang et al., a radial SVM, consisted of 15 tex-
ture features and was able to classify cirrhosis and non-
cirrhosis with a 66.83% accuracy rate [8].
We also tested the models’ performance for the pre-
diction of fibrosis in individual patients. In the first ana-
lysis, the RFC model (model 1) achieved the highest
accuracy in the right lobe segments (AUC = 0.81). Mean-
while, in the second analysis, the RFC (model 3) and
SVM (model 4) classifiers performed equally well for the
prediction of the fibrosis status of the whole liver
(AUC = 0.85 vs. AUC = 0.83, respectively) and the right
lobe (AUC = 0.83 vs. AUC = 0.85, respectively). These re-
sults are comparable with the classification rates
achieved with similar, previously published models. The
model proposed by Lubner et al. could detect advanced
fibrosis (≥F3) with an AUC of 0.82 [18]. Based on the
analysis, we advise that one should apply either model 3
to the right lobe or model 4 to the whole liver to evalu-
ate fibrosis in individual patients. Nevertheless, we
emphasize that the models’ accuracy in predicting a sin-
gle segment can be improved if the training is conducted
on the dataset consisting of the same segments only.
Our research has several limitations. It is a retrospect-
ive study, which was completed in a single institution.
The study population included a small patient cohort of
30 cases. However, we analyzed the anatomic liver seg-
ments separately, and CTTA was performed on 354 seg-
ments. There were mixed etiologies that resulted in
chronic liver disease. Therefore, the population investi-
gated was not homogenous. Recent guidelines recom-
mend non-invasive methods for the initial assessment of
liver fibrosis in both HBV and HCV associated liver dis-
ease. In contrast, liver biopsy is no longer considered as
the first-line method in routine daily practice and only
preferred in selected cases where there is uncertainty or
potential additional etiologies [1–3]. SWE has been ex-
tensively validated and recognized as an accurate tech-
nique for staging liver fibrosis [10, 23]. Thus, similar to
other studies, we used ultrasound elastography for the
assessment of advanced-stage fibrosis instead of liver bi-
opsy [24, 25]. Imaging in PV is routinely performed dur-
ing most of the abdominal CT scans. Thus, fibrosis
associated CTTA features identified in PV can be con-
veniently used for follow-up retrospective assessment
and screening for chronic liver diseases.
Conclusions
This report is among the first to investigate the feasibil-
ity of three-dimensional CTTA in liver fibrosis. The re-
sults reported in this study clearly demonstrate the value
of volume-based CTTA in the evaluation of chronic liver
disease by identifying patients who are at risk of compli-
cations. We demonstrated that features, which describe
grey-level intensities and image heterogeneity, are
strongly associated with the progression of fibrosis. Fi-
nally, we prove that cross-validated machine learning
models based on only a handful of selected features can
reliably differentiate between low-grade and high-grade
fibrosis on different types of scanners.
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